Andrea Galitzia

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 12

Top Topics

Multiple Myeloma

Chronic Lymphocytic Leukemia

Ejection Fraction

Patient Reported

Top Venues

Annals of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Roberta Murru, Andrea Galitzia, Luca Barabino, Roberta Presicci, Giorgio La Nasa, Giovanni Caocci
Prediction of severe infections in chronic lymphocytic leukemia: a simple risk score to stratify patients at diagnosis. Annals of hematology 103 (5) (2024)
Andrea Galitzia, Monica Maccaferri, Francesca Romana Mauro, Roberta Murru, Roberto Marasca
Chronic Lymphocytic Leukemia: Management of Adverse Events in the Era of Targeted Agents. Cancers 16 (11) (2024)
Roberta Murru, Andrea Galitzia, Luca Barabino, Roberta Presicci, Giorgio La Nasa, Giovanni Caocci
Prediction of severe infections in chronic lymphocytic leukemia: a simple risk score to stratify patients at diagnosis. Annals of hematology 103 (5) (2024)
Roberta Murru, Andrea Galitzia, Luca Barabino, Roberta Presicci, Giorgio La Nasa, Giovanni Caocci
Prediction of severe infections in chronic lymphocytic leukemia: a simple risk score to stratify patients at diagnosis. Annals of hematology 103 (5) (2024)
Roberta Murru, Andrea Galitzia, Luca Barabino, Roberta Presicci, Giorgio La Nasa, Giovanni Caocci
Prediction of severe infections in chronic lymphocytic leukemia: a simple risk score to stratify patients at diagnosis. Annals of hematology (2024)
Roberta Murru, Andrea Galitzia, Luca Barabino, Roberta Presicci, Giorgio La Nasa, Giovanni Caocci
Prediction of severe infections in chronic lymphocytic leukemia: a simple risk score to stratify patients at diagnosis. Annals of hematology 103 (5) (2024)
Andrea Galitzia, Monica Maccaferri, Francesca Romana Mauro, Roberta Murru, Roberto Marasca
Chronic Lymphocytic Leukemia: Management of Adverse Events in the Era of Targeted Agents. Cancers 16 (11) (2024)
Roberta Murru, Andrea Galitzia, Luca Barabino, Roberta Presicci, Giorgio La Nasa, Giovanni Caocci
Prediction of severe infections in chronic lymphocytic leukemia: a simple risk score to stratify patients at diagnosis. Annals of hematology 103 (5) (2024)
Silvia Cantoni, Andrea Galitzia, Valentina Mancini, Anna Maria Cafro, Roberto Cairoli
Myeloma's multiple morphologies. EJHaem 5 (1) (2023)
Silvia Cantoni, Andrea Galitzia, Valentina Mancini, Anna Maria Cafro, Roberto Cairoli
Myeloma's multiple morphologies. EJHaem 5 (1) (2023)
Andrea Galitzia, Luca Barabino, Roberta Murru, Giovanni Caocci, Marianna Greco, Giancarlo Angioni, Olga Mulas, Sara Oppi, Stefania Massidda, Alessandro Costa, Giorgio La Nasa
Patients with Chronic Lymphocytic Leukemia Have a Very High Risk of Ineffective Response to the BNT162b2 Vaccine. Vaccines 10 (7) (2022)
Anna Maria Frustaci, Giovanni Del Poeta, Andrea Visentin, Paolo Sportoletti, Alberto Fresa, Candida Vitale, Roberta Murru, Annalisa Chiarenza, Alessandro Sanna, Francesca Romana Mauro, Gianluigi Reda, Massimo Gentile, Marzia Varettoni, Claudia Baratè, Chiara Borella, Antonino Greco, Marina Deodato, Giulia Zamprogna, Roberta Laureana, Alessandra Cipiciani, Andrea Galitzia, Angelo Curto Pelle, Francesca Morelli, Lucio Malvisi, Marta Coscia, Luca Laurenti, Livio Trentin, Marco Montillo, Roberto Cairoli, Alessandra Tedeschi
Coexisting conditions and concomitant medications do not affect venetoclax management and survival in chronic lymphocytic leukemia. Therapeutic advances in hematology 13 (2022)